Master Lecture on Immunotherapy in NSCLC: Metastatic Setting and What is After First Line IO Failure
Luis E. Raez, MD, FACP, FCCP
Masters Debate on: ctDNA in Stage II, Stage III, and Post Resection of Oligometastatic Disease (Part 1)
Caio Max Rocha-Lima, MD, MS
